Microbiology & Infectious Diseases

The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the first-ever twice-yearly injectable HIV prevention therapy.

Almond consumption and gut health may be linked and demonstrate the role of the microbiome in cardiometabolic health, according to a recent review.

Cardiac implantable electronic device infections (CIEDIs) pose significant challenges in diagnosis and management for healthcare professionals.

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

Antibiotic-resistant Escherichia coli and Klebsiella pneumoniae are major causes of urinary tract infections (UTIs) and vaginal inflammation, posing a growing health challenge worldwide.

A systematic review and meta-analysis examining risk factors associated with Mpox infection has provided important insights into transmission patterns and protective factors.

Recent research into monkeypox (mpox) highlights critical gaps in vaccination coverage and infectious disease preparedness, raising concerns about future outbreaks.

A review article highlights the urgent need for healthcare professionals, particularly those in infectious diseases, to take action in reducing the sector’s substantial environmental impact.